Gregory Weaver
2017 - Sevion Therapeutics
In 2017, Gregory Weaver earned a total compensation of $1.6M as Chief Financial Officer at Sevion Therapeutics.
Compensation breakdown
| Option Awards | $1,569,084 |
|---|---|
| Salary | $2,836 |
| Other | $19 |
| Total | $1,571,939 |
Weaver received $1.6M in option awards, accounting for 100% of the total pay in 2017.
Weaver also received $2.8K in salary and $19 in other compensation.
Rankings
In 2017, Gregory Weaver's compensation ranked 6,742nd out of 14,666 executives tracked by ExecPay. In other words, Weaver earned more than 54.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,742 out of 14,666 | 54th |
Division Manufacturing | 2,498 out of 5,772 | 57th |
Major group Chemicals And Allied Products | 808 out of 2,075 | 61st |
Industry group Drugs | 623 out of 1,731 | 64th |
Industry Biological Products, Except Diagnostic Substances | 113 out of 313 | 64th |
Source: SEC filing on April 16, 2018.
Weaver's colleagues
We found three more compensation records of executives who worked with Gregory Weaver at Sevion Therapeutics in 2017.